Ascletis Pharma (1672.HK) Q1 2026 Earnings

31MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.31
-0.24
-0.17
-0.1

Details

Expected EPS
-0.31379777184
Actual EPS
-0.31379777184
Surprise EPS
0
Surprise Percent
+0%

Description

Ascletis Pharma (1672.HK) has reported earnings of -0.31379777184 per share for Q1 2026.

0 Comments

Share your thoughts